Medistim ASA / Fundamentals
Income statement
- Net revenue
€54.04M - Cost of goods sold
€14.70M - Gross profit
€39.34M - SG&A expenses
€6.56M - R&D expenses
€2.51M - EBITDA
€17.38M - D&A
€2.20M - EBIT
€14.57M - Interest expenses
€1.01M - EBT
€14.65M - Tax expenses
€3.48M - Net income
€11.17M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€315.12K - Changes in working capital
-€2.52M - Operating cash flow
€12.83M - Capex
€0.00 - Other investing cash flow
-€2.52M - Net investing cash flow
-€2.52M - Total cash dividends paid
-€9.36M - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
-€793.68K - Net financing cash flow
-€11.22M - Foreign exchange effects
€0.00 - Net change in cash
-€911.81K - Cash at end of period
€8.21M - Free cash flow
€12.83M
Balance sheet
- Cash and cash equivalents
€8.21M - Cash and short-term investments
€8.21M - Total receivables
€10.00M - Inventory
€14.85M - Other current assets
€85.17 - Total current assets
€33.05M - Property, plant & equipment
€5.99M - Goodwill
€1.20M - Intangible assets
€5.32M - Long-term investments
€0.00 - Other non-current assets
€85.17 - Total non-current assets
€12.52M - Total assets
€45.57M - Accounts payable
€0.00 - Short-term debt
€792.06K - Other current liabilities
€9.75M - Total current liabilities
€10.54M - Long-term debt
€1.88M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€2.34M - Total liabilities
€12.88M - Common stock
€390.50K - Retained earnings
€0.00 - Other equity
€28.54M - Total equity
€32.69M - Total liabilities and shareholders' equity
€45.57M
Company information
- Market capitalization
€323.21M - Employees
154 - Enterprise Value
€3.55B
Company ratios
- Gross margin
-
72.8% Better than peer group: 59.5% - EBITDA margin
-
32.2% Much better than peer group: 6.9% - EBIT margin
-
27.0% Much better than peer group: 1.8% - EBT margin
-
27.1% Much better than peer group: 1.9% - Net margin
-
20.7% Better than peer group: 1.8% - ROE
-
34.2% Much better than peer group: 12.1% - ROA
-
24.5% Much better than peer group: 4.0% - Asset turnover
-
118.6% Better than peer group: 106.8% - FCF margin
-
23.7% Better than peer group: 13.8% - FCF yield
4.0% - Efficiency ratio
67.8% - Net sales per employee
-
€350.91K - Net income per employee
-
€72.52K